Contributions are welcomed in the form of original research papers reporting the results of early or late stage clinical investigations or […]
Contributions are welcomed in the form of original research papers reporting the results of early or late stage clinical investigations or […]
Scope: Drug Evaluations must review the clinical data on an approved indication (where relevant), including a review of new efficacy […]
Pharmaprojects is a weekly-updated, enterprise-wide competitor intelligence and R&D (research and development) monitoring service, providing validated, integrated and evaluated information […]
Information coming soon.
Information coming soon.
Word limit: The word limit for Meeting Highlights is 1,000-1,500 words (not including abstract, conference details and references). Every article […]
Prior publication: Expert Reviews will only consider work that has not been previously published in full. Abstract, poster or oral […]
Scope: The aim of a Meta-opinion is to comment on the variety of opinions given in recent papers in the […]
Scope: The aim of Clinical Trial Evaluations is to evaluate the quality of design and implementation of a pivotal study. […]
Scope: Treatment Evaluations review the clinical data on one drug for one approved indication. They should include content on efficacy […]